Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect

Martinez-Martin P, Reddy P, Antonini A, Henriksen T, Katzenschlager R, Odin P, Todorova A, Naidu Y, Tluk S, Chandiramani C, Martin A, Chaudhuri KR.

J Parkinsons Dis. 2011;1(2):197-203. doi: 10.3233/JPD-2011-11037.

Mouse models of cognitive deficits due to alpha-synuclein pathology

Magen I, Chesselet MF.

J Parkinsons Dis. 2011;1(3):217-27. doi: 10.3233/JPD-2011-11043.

Loss-of-function rodent models for parkin and PINK1

Oliveras-Salvá M, Van Rompuy AS, Heeman B, Van den Haute C, Baekelandt V.

J Parkinsons Dis. 2011;1(3):229-51. doi: 10.3233/JPD-2011-11041.

Examination of the UPDRS bradykinesia subscale: equivalence, reliability and validity

Buck PO, Wilson RE, Seeberger LC, Conner JB, Castelli-Haley J.

J Parkinsons Dis. 2011;1(3):253-8. doi: 10.3233/JPD-2011-11035.

Assessing drug-induced dyskinesia in the clinic, the laboratory and the natural environment of patients

Carignan B, Daneault JF, Duval C.

J Parkinsons Dis. 2011;1(4):329-37. doi: 10.3233/JPD-2011-11054.

Stem cells: a model for screening, discovery and development of drugs

Kitambi SS, Chandrasekar G.

Stem Cells Cloning. 2011 Sep 27;4:51-9. doi: 10.2147/SCCAA.S16417. eCollection 2011.

Blue Water Navy Vietnam Veterans and Agent Orange Exposure

Institute of Medicine (US) Committee on Blue Water Navy Vietnam Veterans and Agent Orange Exposure.

Washington (DC): National Academies Press (US); 2011.

Dopamine receptors and Parkinson's disease

Hisahara S, Shimohama S.

Int J Med Chem. 2011;2011:403039. doi: 10.1155/2011/403039. Epub 2011 Jun 13.

The impact of antipsychotic side-effects on attitudes toward medication in patients with schizophrenia and related disorders: a systematic review

Ling CY, Klainin-Yobas P, Ignacio J.

JBI Libr Syst Rev. 2011;9(22):791-832. doi: 10.11124/01938924-201109220-00001.

Free magnesium concentration in the human brain

Iotti S, Malucelli E.

In: Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.

Magnesium in Parkinson’s disease: an update in clinical and basic aspects

Oyanagi K, Hashimoto T.

In: Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.

Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control

Narendra DP, Youle RJ.

Antioxid Redox Signal. 2011 May 15;14(10):1929-38. doi: 10.1089/ars.2010.3799. Epub 2011 Mar 3.

Protective mechanisms by cystatin C in neurodegenerative diseases

Gauthier S, Kaur G, Mi W, Tizon B, Levy E.

Front Biosci (Schol Ed). 2011 Jan 1;3(2):541-54. doi: 10.2741/s170.

Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms

Møller E, Karlsborg M, Bardow A, Lykkeaa J, Nissen FH, Bakke M.

Acta Odontol Scand. 2011 May;69(3):151-7. doi: 10.3109/00016357.2010.545035. Epub 2011 Jan 3.

Young-onset parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome

Mak CM, Sheng B, Lee HH, Lau KK, Chan WT, Lam CW, Chan YW.

Int J Neurosci. 2011 Apr;121(4):224-7. doi: 10.3109/00207454.2010.542843. Epub 2011 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias